English | Español
Patient Daily | May 7, 2023

Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily | May 7, 2023

Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily | May 7, 2023

Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily | May 7, 2023

Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Patient Daily Report | May 5, 2023

Eli Lilly on new Alzheimer's drug: 'We are extremely pleased that donanemab yielded positive clinical results'
Patient Daily | May 4, 2023

Device Talks Boston 2023
Patient Daily | May 4, 2023

Patagonia Health Certified as an NC Minority-Owned Business
Patient Daily | May 4, 2023

RELIAS HONORED AS STEVIE AWARD WINNER FOR CUSTOMER SERVICE DEPARTMENT OF THE YEAR IN 2023 AMERICAN BUSINESS AWARDS

Trending
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'